Ebola virus mutates or affect the efficacy of new drugs
The 20th US researchers say they have found a genetic variation of Ebola occurred in the past 40 years, these mutations may affect the efficacy of drugs being developed for Ebola.
Drug
US scientists want to collect soil samples worldwide development of new drugs
US scientists are calling for the public to join a global collection of soil samples action to facilitate their use of a particular component of soil development of new drugs.
People infected with pathogenic H7N9 virus was discovered a new mechanism
Institute of Microbiology and Epidemiology, Academy of Military Medical Zhou Yusen team Experimental Animal Center, the hospital had a joint forest team, Institute of Basic Medical team Li Yan, chief scientist at Fudan University in Shanghai Shi Bo Jiang team and Germany Inflarx Gmbh company Guoren Feng scientific research team found that people infected H7N9 bird flu virus, a new pathogenic mechanisms.
Chinese study found that dopamine regulation of innate immunity
rofessor, University of Science and Technology of China CRITICAL Research Group, Tian Zhigang research group in collaboration with Beijing Proteome Research Center, Chen Ding study group made an important breakthrough in the study of regulatory mechanisms NLRP3 inflammasome body was found the neurotransmitter dopamine by inhibiting the body relieve NLRP3 inflammasome nervous system inflammation and inflammation.
Japan discovered a hepatitis drug may contain cancer metastasis
A team of researchers at Kyushu University in Japan in the latest issue of the US “Clinical examination magazine” reported that they found in animal studies for the treatment of chronic hepatitis B, to curb cancer metastasis.
First test Ebola vaccine effective in Africa
British medical journal “The Lancet” the report said, the early clinical results of experimenting with an Ebola vaccine in Africa’s “encouraging”, and confirmed the safety of the vaccine is capable of eliciting an immune response. However, its effects and the duration of immunity remains to be verified.
New Antibodies For The Treatment Of Alzheimer's Disease
Japanese researchers have developed an antibody to reduce the lead to Alzheimer’s disease (Alzheimer’s disease) abnormal Tau protein in the brain, and successfully improved the memory of mice. This will help develop the treatment of Alzheimer’s disease drugs.
Research and development of new antibiotics to solve drug resistance
The research team published in the scientific journal Nature reported that through experiments with rats, the drug is expected to open a new page in bacterial diseases war, but licensed for human use may have to wait another 5-6 years.